Burden of Coronary Artery Disease and Peripheral Artery Disease: A Literature Review
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Background . Atherothrombotic disease, including coronary artery disease (CAD) and peripheral artery disease (PAD), can lead to cardiovascular (CV) events, such as myocardial infarction, stroke, limb ischemia, heart failure, and CV death. Aim . Evaluate the humanistic and economic burden of CAD and PAD and identify unmet needs through a comprehensive literature review. Methods . Relevant search terms were applied across online publication databases. Studies published between January 2010 and August 2017 meeting the inclusion/exclusion criteria were selected; guidelines were also included. Two rounds of screening were applied to select studies of relevance. Results . Worldwide data showed approximately 5–8% prevalence of CAD and 10–20% prevalence of PAD, dependent on the study design, average age, gender, and geographical location. Data from the REACH registry indicated that 18–35% of patients with CAD and 46–68% of patients with PAD had disease in one or more vascular beds. Use of medication to control modifiable CV risk factors was variable by country (lower in France than in Canada); statins and aspirin were the most widely used therapies in patients with chronic disease. Survival rates have improved with medical advancements, but there is an additional need to improve the humanistic burden of disease (i.e., associated disability and quality of life). The economic burden of atherothrombotic disease is high and expected to increase with increased survival and the aging population. Conclusion . CAD and PAD represent a substantial humanistic and economic burden worldwide, highlighting a need for new interventions to reduce the incidence of atherothrombotic disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Baseline characteristics and medication use and clinical outcomes in patients with CAD and PAD from the REACH Registries of (a) Canada,a (b) France,b and (c) Germanyc [1, 2]. aPatients enrolled from January to October 2004; mean age 68.4 ± 9.9. bPercentage of patients experiencing at least one CV event (Figure (a): CAD n = 1356, PAD n = 146; Figure (b): CAD n = 2397, PAD n = 882; Figure (c): CAD n = 3328, PAD n = 1303). cPatients enrolled from December 2003 to June 2014; mean age 69.1–71.7 across risk groups. dPatients enrolled from December 2003 to June 2014; mean age 68.0–69.4 across risk groups. ACE, angiotensin-converting enzyme; ASA, acetylsalicylic acid; CAD, coronary artery disease; CV, cardiovascular; PAD, peripheral artery disease.](https://figures.cochat.ai/paper-figures/5e14fc8ebda846379e697620627d3268/burden-of-coronary-artery-disease-and-peripheral-artery-disease-a-literature-figure-1.jpg)
![Figure 2 The persistent risk of MACE (a) up to 3 years following an index MI (adapted from Blin et al., 2016) [3] and (b) up to 4.5 years following an index MI stratified by age (<72 years old versus ≥72 years old) and risk category (low versus higha) (adapted from Jernberg et al., 2015) [4]. aHigh-risk patients were predefined as those with ≥1 of the following risk factors prior to index; MI: diabetes mellitus, at least one MI prior to index MI event, CABG (proxy for multi-vessel CAD), PAD, stroke, heart failure, or diagnosis of chronic renal dysfunction. CABG, coronary artery bypass graft; CAD, coronary artery disease; CV, cardiovascular; HR, high risk; LR, low risk; MACE, major adverse cardiovascular events; MI, myocardial infarction; PAD, peripheral artery disease.](https://figures.cochat.ai/paper-figures/ef7f32f05aeb4415a5daae684132145b/burden-of-coronary-artery-disease-and-peripheral-artery-disease-a-literature-figure-2.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The mere presence of PAD significantly increases the risk of having atherosclerotic disease in other vascular beds.”
From Racial and Ethnic Disparities in Peripheral Artery Disease (2021) · cites this paper as [48]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Approximately, 46% to 68% of patients with PAD also had coronary artery disease (CAD) or cerebrovascular disease.[48][49][50]”
From Racial and Ethnic Disparities in Peripheral Artery Disease (2021) · cites this paper as [48]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
Norgren, L., Hiatt, W. R., Dormandy, J. A., Nehler, M. R., Harris, K. A., & Fowkes, F. G. R. (2007) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2006.12.037 · Cited by 8,191 · cited 1×
“These conditions are characterized by progressive (CLI) or sudden onset (ALI) of pain at rest or nonhealing ischemic wounds or gangrene [27, 44, 45] and can ultimately lead to a loss of limbs [46].”
Background2013 ESC guidelines on the management of stable coronary artery disease
Task Force Members, Montalescot, G., Sechtem, U., Achenbach, S., Andreotti, F., Arden, C., Budaj, A., Bugiardini, R., Crea, F., Cuisset, T., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht296 · Cited by 4,510
Kyu, H. H., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32335-3 · Cited by 4,081
Progress and challenges in translating the biology of atherosclerosis
Libby, P., Ridker, P. M., & Hansson, G. K. (2011) · Nature · doi:10.1038/nature10146 · Cited by 4,010
Hirsch, A. T., Haskal, Z. J., Hertzer, N. R., Bakal, C. W., Creager, M. A., Halperin, J. L., Hiratzka, L. F., Murphy, W. R. C., Olin, J. W., Puschett, J. B., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.174526 · Cited by 3,708
Aboyans, V., Ricco, J.-B., Bartelink, M.-L. E. L., Björck, M., Brodmann, M., Cohnert, T., Collet, J.-P., Czerny, M., De Carlo, M., Debus, S., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx095 · Cited by 3,293
Fihn, S. D., Gardin, J. M., Abrams, J., Berra, K., Blankenship, J. C., Dallas, A. P., Douglas, P. S., Foody, J. M., Gerber, T. C., Hinderliter, A. L., et al. (2012) · Circulation · doi:10.1161/cir.0b013e3182776f83 · Cited by 2,410
Hay, S. I., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32130-x · Cited by 2,083 · cited 1×
“of mortality and morbidity worldwide, atherothrombotic disease places a substantial medical and economic burden on society [7, 12].”
Background2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease
Gerhard-Herman, M. D., Gornik, H. L., Barrett, C., Barshes, N. R., Corriere, M. A., Drachman, D. E., Fleisher, L. A., Fowkes, F. G. R., Hamburg, N. M., Kinlay, S., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.11.007 · Cited by 1,941
Research works printed but not linked: 1
- Gowdak L. H. W. Prevalence of refractory angina in clinical practice Heart and Metabolism 2017 72 9 12 2-s2.0-85018667587
Cited by
Items 201–300 of 482
Barati, M., Amouzeshi, Z., & Nikraftar, F. (2024) · Journal of Education and Health Promotion · doi:10.4103/jehp.jehp_171_24 · Cited by 4
“[1,2] In 2013, it was recognized as the leading cause of death globally, claiming the lives of over 17.3 million individuals.”
InfluentialCarulli, E., McGarvey, M., Chabok, M., Panoulas, V. F., Rosser, G. J., Akhtar, M. M., Smith, R. C., Chandra, N., Al-Hussaini, A., Kabir, T., et al. (2024) · American Heart Journal · doi:10.1016/j.ahj.2024.12.009 · Cited by 4
Wang, G., Zhang, R., Li, X., Zuo, S., Zhang, B., Zhao, Y., Sun, S., Zhang, J., & Liu, X. (2025) · PeerJ · doi:10.7717/peerj.18873 · Cited by 4
Goudarzi, Z., Najafpour, Z., Gholami, A., Keshavarz, K., Mojahedian, M. M., & Babayi, M. M. (2025) · BMC Health Services Research · doi:10.1186/s12913-025-12431-3 · Cited by 4
“PAD and CAD are reported to affect about 13% and 7.2% of people aged greater than 50 years [2].”
InfluentialŞAHAN, D., Akyüz, Y., GÜNEYİ, F., & COŞAR, D. (2025) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2025.01.040 · Cited by 4
Peripheral arterial disease prevalence among sepsis hospitalizations and associated outcomes
Iyer, S., Jarosinski, M. C., Kennedy, J. N., Rudd, K. E., Seymour, C. W., Tzeng, E., Marron, M. M., & Reitz, K. M. (2025) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2025.04.058 · Cited by 4
Critical Limb Ischemia: Update for the Cardiovascular Anesthesiologist
Anderson, P. B., Sen, I., Welker, C. C., Rasmussen, T. E., & Ramakrishna, H. (2022) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2022.06.032 · Cited by 4
Al‐Khadra, Y., Baibars, M., Dakkak, W., Niaz, Z., Deshpande, R., Al-bast, B., Alraies, M. C., & Hafiz, A. M. (2022) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2022.101087 · Cited by 4
GENDER CHARACTERISTICS OF RISK FACTORS IN HYPERTENSION
Esina, E. Y., Kotova, Y. A., & Зуйкова, А. А. (2022) · Bulletin of Medical Science · doi:10.31684/25418475_2022_3_37 · Cited by 4
“Однако, на фоне адекватного контроля АД, у женщин наблюдается менее выраженное снижение общего сердечно-сосудистого риска (ССР), по сравнению с мужчинами [5,6].”
InfluentialTesta, A., Morello, A., Corcione, N., & Biondi‐Zoccai, G. (2023) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001385 · Cited by 4
Naghedi, A., Varastehravan, H., Haghaninejad, H., Naghedi, A., & Farshadi, N. (2023) · Archivos de cardiología de México · doi:10.24875/acm.210004061 · Cited by 4
Ahmed, S., Khatti, S., Shah, G. A., Khan, N., Rai, L., Khan, M. Z., Bari, S. A., & Roy, N. (2023) · Journal of Ayub Medical College Abbottabad · doi:10.55519/jamc-01-10590 · Cited by 4
Cardiovascular risk factors in Sub-Saharan African women: Insights from the TAHES study
Chastaingt, L., Gbaguidi, G. N., Magné, J., Preux, P., Aboyans, V., Houinato, D. S., & Lacroix, P. (2023) · VASA · doi:10.1024/0301-1526/a001058 · Cited by 4
Motawea, K. R., Elhalag, R. H., Rouzan, S. S., Talat, N. E., Reyad, S. M., Chèbl, P., Mohamed, M. S., & Shah, J. (2023) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2023.101812 · Cited by 4
Ren, L., Liu, W., Chen, S., & Zeng, H. (2023) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.2023.j097 · Cited by 4
Uttinger, K., Medicke, P., Aldmour, S., Wiegering, A., Steiner, S., Schmidt, A., & Branzan, D. (2024) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2024.07.025 · Cited by 4
The predictors of coronary slow flow in patients undergoing coronary angiography
Ermawan, R., Pintaningrum, Y., & Indrayana, Y. (2024) · The Egyptian Heart Journal · doi:10.1186/s43044-024-00536-9 · Cited by 4
“Coronary artery disease (CAD) continues to be a major contributor to mortality and morbidity worldwide, with a high prevalence rate ranging from 5 to 8% [1].”
BackgroundBate, K. A., Genetzakis, E., Vescovi, J., Gray, M. P., Celermajer, D. S., McGuire, H. M., Grieve, S. M., Vernon, S. T., Cartland, S. P., Yang, J. Y. H., et al. (2024) · Biomolecules · doi:10.3390/biom14091119 · Cited by 4
“When these biomarkers were assessed using multi-variable regression analysis adjusting for the standard factors associated with CAD, no additional predictive ability for disease prevalence or severity was demonstrated.”
MethodWoo, K. Y., Murphy, C., Gregg, E., Moralejo, J., LeBlanc, K. A., & Brandys, T. (2024) · Journal of Wound Ostomy and Continence Nursing · doi:10.1097/won.0000000000001112 · Cited by 4
Chen, W., Liu, Y., Deng, X., Li, B., Wang, H., Wei, G., Chen, K., & Wang, S. (2024) · International Journal of General Medicine · doi:10.2147/ijgm.s486187 · Cited by 4
Quan, X., Liu, Y., Xiong, H., Song, P., Wang, D., Liu, X., Chen, Q., Hu, X., & Shi, M. (2024) · Journal of Endovascular Therapy · doi:10.1177/15266028241289083 · Cited by 4
Esin, F. K., Ince, H., Kırış, T., Çelik, A., & Karaca, M. (2024) · International Journal of the Cardiovascular Academy · doi:10.4274/ijca.2024.18291 · Cited by 5
Wang, M., Zheng, C., Yang, L., Su, J., Wang, W., & Sheng, J. (2025) · European Journal of Radiology Open · doi:10.1016/j.ejro.2025.100637 · Cited by 4
“Atherosclerosis is a contributing factor to severe vascular lesions, including coronary artery disease, acute aortic syndrome, and cerebral and carotid artery stenosis [1 – 3].”
Dziedzic, E. A., Czernicka, A., Gąsior, J. S., Szamreta-Siwicka, A., Wodejko-Kucharska, B., Maciński, P., Arbaszewska, A., Adler, K., Osiecki, A., & Kochman, W. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14134537 · Cited by 5
“These processes collectively promote the formation of atherosclerotic plaques [2].”
Chang, Y.-S., Lee, L.-Y., & Lee, I. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s330606 · Cited by 4
“PAD is associated with disability and mortality,(2,3) and carries considerable economic and humanistic burdens worldwide.(4,5) Based on the American Heart Association/American College of Cardiology guidelines set in 2016 for the management of patients with lower-extremity PAD, the resting ankle-brachial index (ABI) is…”
BackgroundTransient ischemic attack and coronary artery disease: a two-sample Mendelian randomization analysis
Qi, X., Wang, S., Qiu, L., Chen, D., Huang, Q., Ouyang, K., & Chen, Y. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1192664 · Cited by 4
“with CAD also impose significant economic burdens (5).”
BackgroundA QSPR study of coronary artery disease drugs using eccentricity-based indices
Iqbal, N., Akhter, S., Alraih, A. M., Iqbal, Z., Aslam, A., & Tola, K. A. (2025) · Scientific Reports · doi:10.1038/s41598-025-23073-0 · Cited by 3
Kızılyel, F., Cebe, T., Rum, M., Bozalı, K., Turgut, Ş., Yilmaz, M. E., Kehlіbar, T., & Ketenci, B. (2025) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-025-03751-w · Cited by 3
“Atherosclerosis, the fundamental pathophysiological process underlying coronary artery disease (CAD), exacerbates vascular dysfunction following surgery [9].”
InfluentialKang, B., Zhang, C., Li, J., & Chen, L. (2025) · The Egyptian Heart Journal · doi:10.1186/s43044-025-00707-2 · Cited by 3
“In 2022 alone, CAD accounted for over 9.2 million deaths, imposing substantial healthcare and economic burdens world-wide [3–5].”
InfluentialHou, B., Qiao, J., Ran, Z., Li, Y., Huang, Z., Luo, X., & Li, X. (2026) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2026.106338 · Cited by 3
Hamzah, K. A., Kurmasha, Y. H., Abdrabo, M. F., Srour, M. F., Al‐Shammari, A. S., Badi, M., Shweliya, M. A., Jena, N. K., & Sattar, Y. (2026) · International Journal of Cardiology Cardiovascular Risk and Prevention · doi:10.1016/j.ijcrp.2026.200590 · Cited by 4
“Although the Global Burden of Disease (GBD) 2021 estimates that over 113 million individuals worldwide are affected by PAD [2], a recent study projected a 220% increase in this prevalence by 2050 [3].”
Sharma, S., & Mehta, A. (2026) · Journal of Functional Foods · doi:10.1016/j.jff.2026.107207 · Cited by 3
Understanding peripheral arterial disease in the current era
Behrendt, C., Norgren, L., Nicolajsen, C. W., Powell, J. T., Chuter, V., Gupta, P. C., Woo, K., & Nordanstig, J. (2026) · The Lancet · doi:10.1016/s0140-6736(26)00846-9 · Cited by 4
Sakuma, Y., Shimizu, T., Kurosawa, Y., Ohara, H., Muto, Y., Sato, Y., Kiko, T., Sato, A., Misaka, T., Yoshihisa, A., et al. (2023) · Journal of Cardiology · doi:10.1016/j.jjcc.2023.04.012 · Cited by 3
Kim, J., Hong, J. H., Jung, J. G., Jung, W. T., Nam, K., Roh, J. S., Choi, Y. W., Bang, J., Huh, H. W., Lee, H. J., et al. (2024) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.1390 · Cited by 2
Ferko, N. C., Priest, S., Almuallem, L., Mooradally, A. W., Wang, D., Ramirez, A. O., Szabó, E., & Cabra, A. (2024) · Journal of Medical Economics · doi:10.1080/13696998.2024.2345507 · Cited by 3
Reshadmanesh, T., Behnoush, A. H., Farajollahi, M., Khalaji, A., Ghondaghsaz, E., & Ahangar, H. (2024) · Clinical Cardiology · doi:10.1002/clc.24315 · Cited by 3
“…progression over decades, it is essential to identify high ‐ risk patients without further delays to prevent severe cardiovascular events since the prevention of fatal consequences of acute coronary syndrome (ACS) needs prompt evaluation and early risk stratification of these individuals [9, 10].”
BackgroundСимакова, И. А., Аракелян, В. С., & Папиташвили, В. Г. (2024) · The Bulletin of Bakoulev Center Cardiovascular Diseases · doi:10.24022/1810-0694-2024-25-4-279-287 · Cited by 3
Ankle-Brachial Index in patients with acute myocardial infarction
Verdoia, M., PATTI, F., CONTI, B., Castagno, C., Aronici, M., Forliti, E., & Rognoni, A. (2025) · Minerva Cardiology and Angiology · doi:10.23736/s2724-5683.25.06763-8 · Cited by 3
del Castillo, M. G., Hernando, D., Orini, M., Laguna, P., Viik, J., Bailón, R., & Pueyo, E. (2021) · Philosophical Transactions of the Royal Society A Mathematical Physical and Engineering Sciences · doi:10.1098/rsta.2020.0261 · Cited by 3
Cardiovascular Predictors of Intracerebral Hematoma Expansion
Sawalha, K., Kamdar, H. A., Gullo, T. R., Okere, S., Hamed, M., Hinduja, A., & Hussein, O. (2022) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2022.106527 · Cited by 3
Cardiovascular disorders and herbal medicines in India
Mishra, A., Vijayaraghavalu, S., & Kumar, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90572-5.00005-6 · Cited by 5
Syu, D.-K., Hsu, S.-H., Yeh, P.-C., Lee, T.-L., Kuo, Y.-F., Huang, Y.-C., Jiang, C., & Chen, M. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191811327 · Cited by 3
“Despite a decline in mortality rates, PAD remains highly prevalent due to the aging population, with a prevalence of approximately 10 to 20% [1].”
BackgroundHeintjes, E. M., Anastassopoulou, A., Kuiper, J. G., Bilitou, A., Beest, F. J. A. P., Herings, R. M. C., Postma, M. J., & Jukema, J. W. (2022) · Current Medical Research and Opinion · doi:10.1080/03007995.2022.2129228 · Cited by 3
“0) History of ASCVD, n (%) 35,905 (66) 35,905 (95) – Affected vascular bed, n (%) Coronary arteries 26,604 (49) 26,604 (70) – Cerebrovascular arteries 14,458 (27) 14,458 (38) – Peripheral arteries 2847 (5) 2847 (7) – Number of affected vascular beds, n (%) 1 28,285 (52) 28,285 (74) – 2 7236 (13) 7236 (19) – 3 384 (1)…”
Impact of socioeconomic disparities on major lower extremity revascularization complications
McElroy, I. E., Pillado, E. B., Greene, A. J., Majumdar, M., Kirshkaln, A., Nuzzolo, K., Malek, J. Y., & Dua, A. (2022) · Vascular · doi:10.1177/17085381221140165 · Cited by 3
EL‐Andari, R., Bozso, S. J., Fialka, N. M., Kang, J. J. H., Hassanabad, A. F., & Nagendran, J. (2023) · Cardiology in Review · doi:10.1097/crd.0000000000000524 · Cited by 3
Practical aspects of managing patients with cardiogenic shock
Novosadov, M., Novosadov, V. M., Dzhioeva, O. N., & Drapkina, O. M. (2023) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2023-5337 · Cited by 3
Kotlyarov, S. N. (2023) · Biomedicines · doi:10.3390/biomedicines11041216 · Cited by 3
“Introduction Atherosclerosis is a major problem in modern society because of the high prevalence of atherosclerotic cardiovascular diseases (ASCVDs) among populations in many countries [1].”
BackgroundTestoni, I., Ronconi, L., Lampis, F., Iacona, E., Zammarrelli, J., Pompele, S., Valle, R., Boscolo, G., & Leo, D. D. (2023) · Behavioral Sciences · doi:10.3390/bs13050430 · Cited by 3
“Many studies have reported the severe burden presented by cardiovascular and coronary diseases in terms of obstacles to the patient’s social relationships, work and quality of life [21] as well as worsening psychological well-being expressed by anxiety, depressed mood and even symptoms of post-traumatic stress [22].”
BackgroundJeong, J.-O., Ju, Y. M., Kang, H., Atala, A., Yoo, J. J., & Lee, S. J. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c13738 · Cited by 6
Long, C. A., Williams, A. O., Jacobsen, C. M., McGovern, A. M., Hargens, L. M., Duval, S., & Jaff, M. R. (2023) · Journal of Comparative Effectiveness Research · doi:10.57264/cer-2023-0048 · Cited by 3
Porras, C. P., de Boer, A. R., Koop, Y., Vaartjes, I. C. H., Teraa, M., Hazenberg, C. E. V. B., Verhaar, M. C., & Vernooij, R. W. M. (2024) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2024.04.039 · Cited by 3
Khalpey, Z. I., Kumar, U. A., Aslam, U., Deckwa, J., & Konhilas, J. P. (2024) · Cureus · doi:10.7759/cureus.60254 · Cited by 3
“CAD impacts 154 million people worldwide and represents 32.7% of cardiovascular disease [1,2].”
BackgroundInfluentialAssociation Between Coronary Artery Disease and Herpes Zoster: A Cohort Study in Taiwan
Lai, S., Kuo, Y., & Liao, K.-F. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae394 · Cited by 3
“Coronary artery disease (CAD) is a leading cause of death in developed and developing countries, and global data reveal that the prevalence of CAD is about 5% to 8% [1, 2].”
BackgroundPriest, S., Mooradally, A. W., Szabó, E., & Cabra, A. (2024) · Journal of Medical Economics · doi:10.1080/13696998.2024.2431413 · Cited by 3
Lakkireddy, D., Angiolillo, D. J., Charlton-Ouw, K. M., Jefferson, B. K., Peeran, S. M., Bisharat, M. B., Ortega‐Paz, L., Harxhi, A., Kaul, S., Michaud, E., et al. (2024) · Clinical Cardiology · doi:10.1002/clc.70039 · Cited by 3
Liang, S.-B., Wang, Y.-F., Niu, Z.-C., Li, Y., Zheng, H., Huan, J.-M., Yuan, J., Robinson, N., Liu, J.-P., & Li, Y. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1499585 · Cited by 3
The importance of the diet in the prevention of atherosclerosis progression
Mustafin, R. N., & Galieva, E. A. (2024) · Voprosy Pitaniya · doi:10.33029/0042-8833-2024-93-6-16-26 · Cited by 3
Giovannini, S., Biscetti, F., Brau, F., Biscotti, L., Santoliquido, A., Pitocco, D., Bernabei, R., & Flex, A. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2022.111677 · Cited by 3
A global burden in cardiovascular medicine of the 21st century: lower extremity artery disease
Schlager, O. (2024) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwae041 · Cited by 3
Mishra, K., Mohammad, K. O., Patel, D., Makhija, R. R., Siddiqui, T., Abolbashari, M., & Rodriguez, J. B. C. (2023) · Angiology · doi:10.1177/00033197221146161 · Cited by 2
“12 PAD was also found to be associated with a nearly 2-fold increase in the prevalence of CHF.”
BackgroundChurch, L. A., Spahr, A., Marschner, S. L., Wallace, J. P., Chow, C. K., & King, S. (2024) · PLoS ONE · doi:10.1371/journal.pone.0306882 · Cited by 2
Yeh, J., Yip, H., Shao, P., Chiang, J. Y., Wu, S., Sung, P., Sheu, J., & Guo, J. (2024) · American Journal of Translational Research · doi:10.62347/ocft1003 · Cited by 2
Ion, A. P., Asztalos, A. I., Ciucanu, C. C., Russu, E., Mureșan, A. V., Arbănași, E. M., Chirilă, T. V., Strnad, G., & Arbănași, E. M. (2024) · Methods and Protocols · doi:10.3390/mps7060090 · Cited by 2
“The most common cardiovascular diseases include coronary atherosclerosis [3], stroke [4], and peripheral arterial disease (PAD) [3,5].”
Relationship between LE8 score and peripheral arterial disease from NHANES perspective
Liu, Z., Zhang, Z., & Li, T. (2025) · VASA · doi:10.1024/0301-1526/a001169 · Cited by 2
Allagbé, I., Servier, C., & Faou, A.-L. L. (2025) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2025.03.002 · Cited by 2
Lai, J., Gong, L., Liu, Y., Li, Y., Ni, J., & Zhou, D. (2025) · PeerJ · doi:10.7717/peerj.19271 · Cited by 2
“LDL-C and TG are closely associated with obesity, atherosclerosis, type 2 diabetes mellitus (T2DM), hypertension, and other related diseases ( Bauersachs et al., 2019 ).”
Sex Disparities in Medical Management: Influence on Morbidity in Peripheral Arterial Disease
Zhong, Q., Ahmed, U., Yunus, R. A., Saeed, S., Sohail, M., Manji, A. A.-K., Robitaille, M. J., Schermerhorn, M. L., Mahmood, F. U., & Matyal, R. (2025) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2025.04.109 · Cited by 2
Kirov, H., Caldonazo, T. M. M., Woehlecke, H., Fazzini, L., Fischer, J., Costa, V., Amorim, P., Runkel, A., Rodrigues, E., Mukharyamov, M., et al. (2025) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2025.100606 · Cited by 2
A rapid review of pathways to diagnosis for people living with peripheral artery disease
Clothier, Z., Armes, J., Heiß, C., & Harris, J. (2025) · VASA · doi:10.1024/0301-1526/a001241 · Cited by 2
Zhang, B., YuRong, S., Bai, H., JingSi, Z., Lü, Y., FengYi, L., Yang, Q., YangYou, Z., Luan, B., YanChun, D., et al. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1707981 · Cited by 2
“Epidemiological data indicate that CHD accounts for approximately 32.7% of global heart disease and 1.7% of the total disease burden (4).”
InfluentialYao, F., Li, F., Gai, S., Chen, Y., Liu, F., Zhang, X., Li, J., Mao, L., Guo, L., Xing, K., et al. (2026) · Nature Cell Biology · doi:10.1038/s41556-026-02022-7 · Cited by 2
Effect of Lentivirus‐Mediated miR‐499a‐3p on Human Umbilical Vein Endothelial Cells
Zheng, H., Li, J., Chen, Y., Gong, D., Wen, J., Mai, L., & Zeng, Z. (2020) · BioMed Research International · doi:10.1155/2020/9372961 · Cited by 2
Optimization of the Statin Therapy Algorithm in Outpatient Practice: Adherence and Economic Benefits
Давиташвили, С. А., Небиеридзе, Д. В., Ахмеджанов, Н. М., Лишута, А. С., & Safaryan, A. S. (2020) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2020-11-10 · Cited by 2
“потребность в этом существенно возросла [3].”
Review of the differences in outcomes between males and females after revascularization
EL‐Andari, R., Bozso, S. J., Kang, J. J. H., Hedtke, H., & Nagendran, J. (2021) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000872 · Cited by 2
Quijandría-Cárdenas, G., Bustamante, M. D. F., Sánchez, L. R. P., Sáenz-Bustamante, S., & Yovera-Aldana, M. (2022) · ACTA MEDICA PERUANA · doi:10.35663/amp.2022.394.2448 · Cited by 3
Jones, I. C., & Dass, C. R. (2023) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgad037 · Cited by 2
Potensi Efek Terapeutik Propolis sebagai Pencegahan dan Pendukung Terapi Penyakit Jantung Koroner
Lasminiati, K. D., & Noviyani, R. (2023) · Prosiding Workshop dan Seminar Nasional Farmasi · doi:10.24843/wsnf.2022.v02.p54 · Cited by 2
“Hal ini menghabiskan biaya lebih dari 200 miliar dolar setiap tahunnya bagi sistem pelayanan kesehatan di Amerika Serikat [2], [3].”
BackgroundLi, Q., & Li, J. (2024) · Physiological Reports · doi:10.14814/phy2.15933 · Cited by 2
“…worldwide (Criqui & Aboyans, 2015; Fowkes et al., 2017), who are at a high risk of various cardiovascular disorders such as myocardial infarctions and cerebral vascular accidents because a higher BP response is seen during exercise (Anand et al., 2018; Bauersachs et al., 2019; Ouriel, 2001).”
BackgroundFeasibility of the Anchor‐Free Deep Learning Method in Coronary Stenosis Automatic Detection
Yue, H., Yu, W., Dong, J., Lai, Y., Wu, Y., Zhao, H., Song, Y., Zhao, L., Wang, H., Zhang, J., et al. (2024) · Journal of Interventional Cardiology · doi:10.1155/2024/2606789 · Cited by 2
Sivakumar, A., Satam, K. K., Wu, Z., Alameddine, D., Aboian, E., Chaer, R. A., Schermerhorn, M. L., Moreira, C., Guzman, R. J., & Chaar, C. I. O. (2024) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2024.07.021 · Cited by 2
Wu, C., Yar, N., & Chen, Y. (2024) · Renal Failure · doi:10.1080/0886022x.2024.2380754 · Cited by 2
“This progressive disease shares similar major cardiovascular risk factors (e.g., smoking, diabetes mellitus [DM], hypertension, and hypercholesterolemia) and is associated with adverse cerebrovascular events, cardiovascular events, and limb outcomes [4,5].”
BackgroundAssociation and Prognostic Implications of Peripheral Arterial Disease and Calcific Aortic Stenosis
Faure, M., Jouan, J., Lacroix, P., Blossier, J.-D., Preux, P., Chastaingt, L., Boukhris, M., Cané, M., Lux, G., Aboyans, V., et al. (2024) · Journal of the Heart Valve Society · doi:10.1177/30494826241296674 · Cited by 3
“Among patients with PAD, 33.1% (95% CI: 25.0-41.2) also had concomitant CAD and CVD. 42.0-60.0), P = .002; respectively.”
InfluentialElbadr, M. M., Galal, H. A., Hetta, H. F., Elfadil, H., Alanazi, F. E., Fawzy, S., Aljohani, H. M., Ellah, N. H. A., Ali, M. F., Dyab, A. K., et al. (2025) · Diseases · doi:10.3390/diseases13030087 · Cited by 2
Barata, B. F., Liao, G., Borghesan, G., McCutcheon, K. R. G., Bennett, J., Rosa, B., de Mathelin, M., Nageotte, F. P., Gora, M. J., Sloten, J. V., et al. (2025) · Medical & Biological Engineering & Computing · doi:10.1007/s11517-025-03323-z · Cited by 3
“Cardiovasculardiseasesaretheprimarycauseofdeathworld-wide, reported to be responsible for 32% of deaths globally in 2019 [1] and with coronary artery disease being responsible for about one third of these deaths [2].”
Ma, R., Wang, R., Wang, B., Tang, Z., Qiu, T., Lu, Y., & Liu, G. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1555880 · Cited by 2
“Epidemiological data indicate that the prevalence of CAD ranges from approximately 5% to 8% worldwide (15), while the prevalence of MI has been reported at 3.8% among individuals younger than 60 years and 9.5% among those older than 60 years (16).”
InfluentialShalnova, S. A., Яровая, Е. В., Makarova, Y. K., Kutsenko, V. A., Владимировна, К. А., Balanova, Y. А., Имаева, А. Э., & Аркадьевна, М. Г. (2020) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2020-10-01 · Cited by 2
“ПХ и СТ 7,17 [4,6211,15] <0,005 2,54 [1,53-4,20] <0,005”
InfluentialChowdekar, V. S., & Peddi, N. (2020) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20204940 · Cited by 2
Bhale, A. S., & Venkataraman, K. (2023) · Bioscience Reports · doi:10.1042/bsr20230124 · Cited by 2
Khan, A., Khan, M. G., Khalil, I. K., Khan, S. M., shah, H., & Khan, H. A. (2024) · Journal of Health and Rehabilitation Research · doi:10.61919/jhrr.v4i1.578 · Cited by 2
Korosoglou, G., & Maylar, N. M. (2021) · International journal of cardiac imaging · doi:10.1007/s10554-021-02361-6 · Cited by 2
Is colchicine on its way to a place in the polypill for cardiovascular prevention?
Botto, F. O., & García-Zamora, S. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.118594 · Cited by 2
Das, G. C., Potdar, P., Ghosh, R., Dubey, S., Ray, B. K., & Modrego, P. J. (2022) · Annals of Medical Science and Research · doi:10.4103/amsr.amsr_12_22 · Cited by 1
Almutairi, A. H., Alhassan, S. A., Almutairi, F. A., Alharthi, B. A., Aljabr, S. A., Alabdulmonem, R. A., Altariqi, W. M., Alaboody, Z. M., Almutairy, A. K., Alqahtani, M. A. N., et al. (2024) · Cureus · doi:10.7759/cureus.52497 · Cited by 2
“This translates to 15.5 million Americans who had the illness at this time [3,4].”
BackgroundInfluentialEsna‐Ashari, F., Hosini, M. E., & Fariba, F. (2023) · Armaghane Danesh · doi:10.61186/armaghanj.28.4.507 · Cited by 1
Gohil, M. N., Muruganantham, B., Raval, M., & Bearne, L. (2024) · Journal of Vascular Nursing · doi:10.1016/j.jvn.2024.05.004 · Cited by 1
Milovanović, A., Isailovic, V. M., Saveljic, I. B., & Filipović, N. (2024) · Technology and Health Care · doi:10.3233/thc-240803 · Cited by 1
“In more than 95% of cases, it is caused by arteriosclerosis that narrows the coronary arteries that supply the heart with blood and oxygen [1].”
Increasing Incidence of Coronary Artery Disease in Younger Men: Case Study of a 39-Year-Old
Elgaali, J., de la Cruz, P. C., Hussaini, S. I., & Naseer, M. (2024) · Cureus · doi:10.7759/cureus.74516 · Cited by 1
“In the United States, patients on average incur an additional annual cost of about $30,000 after being diagnosed with the condition, cumulatively costing the country over $200 billion annually [2,4].”
InfluentialLeukocytosis as a Risk Factor for Coronary Artery Disease: Pathophysiology and Epidemiology
Amin, T., Rasool, M. H. U., OZKAN, B. I., Swaminathan, G., RAUF, F., PATRIZI, S., Sethi, A. K., Frishman, W. H., Aronow, W. S., & Ahmed, M. S. (2024) · Cardiology in Review · doi:10.1097/crd.0000000000000824 · Cited by 1
Li, Q., Cao, F., Gao, X., Xu, Y., Li, B., & Hu, T. (2024) · Global Heart · doi:10.5334/gh.1373 · Cited by 1
Metadata
- Authors
- Bauersachs, R., Zeymer, U., Brière, J.-B., Marre, C., Bowrin, K., & Huelsebeck, M.
- Affiliations
- Johannes Gutenberg University Mainz (DE)
- Klinikum Ludwigshafen (DE)
- Bayer (Germany) (DE)
- Creativ-Ceutical (France) (FR)
- Bayer (United Kingdom) (GB)
- Corresponding author
- Bauersachs, Rupert
- Venue
- Cardiovascular Therapeutics
- Publisher
- Wiley
- Published
- 2019-11-26
- Volume
- 2019
- Pages
- 1-9
- ISSN
- 1755-5914 (ISSN-L)
- 1755-5922
- PMC
- PMC7024142
- OpenAlex
- W2990657953
- Semantic Scholar
- 7306e92becdce616c64c569876ca723660f04cb3
- Cited by
- 449
- References
- 52
- Citations by year
- 2026: 39 · 2025: 80 · 2024: 118 · 2023: 102 · 2022: 64 · 2021: 38 · 2020: 8
- FWCI
- 5.67
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Cardiovascular Therapeutics (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt) (submittedVersion, cc-by)
- Funders
- Bayer AG
- Janssen Pharmaceuticals
- Topics
- Health Sciences › Medicine › Surgery › Peripheral Artery Disease Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Health Sciences › Medicine › Epidemiology › Healthcare Systems and Public Health
- Keywords
- coronary artery disease, peripheral arterial disease, atherothrombosis, disease burden, economic burden, humanistic burden, prevalence, quality of life, disability, statins, aspirin, cardiovascular risk management, survival rate, population aging, unmet needs
- MeSH terms
- Aged, Coronary Artery Disease, Female, Health Services Needs and Demand, Humans, Male, Prognosis, Risk Factors, Global Health, Incidence, Prevalence, Health Care Costs, Cost of Illness, Peripheral Arterial Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.